1832 Asset Management
WST icon

1832 Asset Management’s West Pharmaceutical WST Stock Holding History

1832 Asset Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-23,700
Closed -$7.11M – 737
2024
Q3 		$7.11M Buy
+23,700
New +$7.26M 0.01% 370
2023
Q3 		– Sell
-5
Closed -$1.91K – 924
2023
Q2 		$1.91K Buy
+5
New +$1.79K ﹤0.01% 817
2022
Q2 		– Sell
-753
Closed -$305K – 969
2022
Q1 		$305K Buy
+753
New +$295K ﹤0.01% 691
2021
Q4 		– Sell
-523
Closed -$228K – 873
2021
Q3 		$228K Buy
+523
New +$220K ﹤0.01% 668
2020
Q4 		– Sell
-482,200
Closed -$133M – 752
2020
Q3 		$133M Buy
482,200
+65,400
+16% +$17.3M 0.35% 85
2020
Q2 		$92.5M Buy
+416,800
New +$81.9M 0.28% 94
2019
Q1 		– Sell
-878,420
Closed -$86.1M – 719
2018
Q4 		$86.1M Buy
878,420
+2,400
+0.3% +$260K 0.34% 74
2018
Q3 		$108M Buy
876,020
+217,460
+33% +$24.4M 0.35% 72
2018
Q2 		$65.4M Sell
658,560
-143,470
-18% -$13.2M 0.22% 103
2018
Q1 		$71.2M Buy
802,030
+88,670
+12% +$8.29M 0.26% 95
2017
Q4 		$70.1M Buy
713,360
+65,390
+10% +$6.41M 0.23% 96
2017
Q3 		$60.5M Buy
647,970
+372,070
+135% +$33.7M 0.21% 96
2017
Q2 		$26.1M Buy
275,900
+166,200
+152% +$15.3M 0.12% 163
2017
Q1 		$8.97M Buy
+109,700
New +$9.17M 0.03% 267

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return

1832 Asset Management's WST Position: Q4 2024 in Review

1832 Asset Management sold out of West Pharmaceutical (WST) in Q4 2024, closing a stake of 23,700 shares — an estimated $7.11M sold.

1832 Asset Management first reported a position in WST in Q1 2017 and held it in 14 quarters. The position peaked at $133M in Q3 2020. 748 funds tracked by Wall St. Rank hold WST as of Q4 2024.

  • 1832 Asset Management reported no remaining West Pharmaceutical position as of Q4 2024 after selling out during the quarter.
  • 1832 Asset Management sold 23,700 West Pharmaceutical shares in Q4 2024, an estimated $7.11M.
  • 1832 Asset Management first reported a position in West Pharmaceutical in Q1 2017 and held it in 14 quarters.
  • 1832 Asset Management's West Pharmaceutical position peaked at $133M in Q3 2020.
  • 748 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2024.

Based on 1832 Asset Management's 13F filing for Q4 2024, filed 14 Feb 2025.